• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

QUIZ: Dermoscopy and Melanoma Detection


Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month.

Last week, we invited you to participate in the second of our weekly polls this month for Skin Cancer Awareness Month. We asked questions related to clinical features of amelanotic melanoma, the significance of the histopathological finding "lentiginous growth pattern," dermatofibrosarcoma protuberans, lentigo maligna and lentigo maligna melanoma, and Merkel cell carcinoma.

If you have not yet taken our quiz, feel free to do so here. Later in the week, we also provided a rundown of the answers to the quiz along with additional information about melanoma classification and staging. Review your responses here.

This week, we have put together a 5-question quiz testing your knowledge of dermoscopy and melanoma detection.

At the end of the week, we will provide a rundown of answers to the quiz with additional resources and information for each question.

Have an idea for a quiz? Feel free to share your insights and knowledge of rosacea by emailing our team at DTEditor@mmhgroup.com.

Dermatology Times invites you to join us in advancing understanding, promoting dialogue, and ultimately improving outcomes for individuals living with skin cancer. Stay tuned for our weekly quizzes, and let's work together to make a difference this Skin Cancer Awareness Month.

What is the characteristic dermoscopic feature known as "negative pigment network" indicative of?

Review recent Dermatology Times skin cancer news and content:

Skin Cancer Roundup: The Year so Far

This Skin Cancer Awareness Month, take a look at previous coverage from 2024.

Sonidegib Plus Calcium Supplementation for Improved Management of BCC and HHI-Related Muscle Spasms

Muscle spasms are the most common adverse event experienced by patients treated with hedgehog inhibitors for basal cell carcinomas.

Merck Halts Dosing of Anti-TIGIT Antibody in KeyVibe-010 Melanoma Study

The analysis revealed a higher rate of discontinuations due to immune-mediated adverse experiences.

Asian American and Pacific Islander Patients Face Increased Odds of Melanoma Treatment Delay

Researchers say addressing socioeconomic differences may be the key to addressing this disparity.

QUIZ RECAP: Advanced Skin Cancer Awareness

Earlier this week, we shared our second Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.